Lymphoma in Cats

The past decade has witnessed active research in the field of feline veterinary oncology, focused on a deeper understanding of risk factors, key pathogenic mechanisms, prognostic markers, refinement of surgical techniques, exploration of new therapeutic targets, and neoplasia prevention. Despite certain advancements, the issue of verifying and predicting the biological behaviour of individual tumours remains unresolved. Among them is lymphoma, which often presents a chronic course (without athognomonic signs) and demonstrates significant variability in tissue involvement, explaining the considerable fluctuations in its recordedfrequency, ranging from 3.6 to 22%. The range of anatomical forms also varies significantly, with alimentary (up to 40%) and multicentric (up to 30%) lymphomas most commonly diagnosed. The probability of verifying numerous histopathological types (T-cell lymphoma, B-cell lymphoma) and their subtypes correlates with the anatomical form of lymphoma. A concerning trend is the dynamic increase in the registration of new and rare forms of lymphoma (primary lymphoma of the adrenal glands, pericardium, ocular globe, etc.), indicating the variability of pathogenetic mechanisms, likely due to enhanced genomic instability. In addition to well-established risk factors for lymphoma in cats, the adverse anthropogenic impact has become relevant. The initiation of lymphoma in cats due to tobacco smoke has been proven. The significance of age, breed, and gender predisposition as risk factors for lymphoma has been debated and largely depends on the region. The absence of vaccination against viraldiseases in cats increases the risk of lymphoma. The most significant risk factors for the development of lymphoma in cats are leukosis and immunodeficiency agents, although their etiological role has significantly decreased in recent years. Current research demonstrates the active involvement of chromosomal aberrations and chronic inflammation in lymphoma development. Kidney transplantation and immunosuppressive therapy increase the likelihood of lymphoma development in cats almost sevenfold.A risk factor requiring further study is genetic heredity, currently identified in Siamese, British, and Oriental shorthair cats.